Apixaban for the Secondary Prevention of Thrombosis Among Patients With Antiphospholipid Syndrome: study rationale and design (ASTRO-APS). Clin Appl Thromb 625. VITATOPS Trial Study Group. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet 626. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565 575. doi: 10.1001/jama.291.5.565 627. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S; SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ. 2010;341:c6273. doi: 10.1136/bmj.c6273 628. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Euro-Phospholipid; Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lower- ing with folic acid and B vitamins in vascular disease. N Engl J Med. 629. Hsu CY, Chiu SW, Hong KS, Saver JL, Wu YL, Lee JD, Lee M, Ovbiagele B. Folic acid in stroke prevention in countries without mandatory folic acid food fortification: a meta-analysis of randomized controlled trials. J Stroke. 630. Li Y, Huang T, Zheng Y, Muka T, Troup J, Hu FB. Folic acid supplemen- tation and the risk of cardiovascular diseases: a meta-analysis of ran- domized controlled trials. J Am Heart Assoc. 2016;5:e003768. doi: 631. Mart -Carvajal AJ, Sol I, Lathyris D, Dayer M. Homocysteine-lowering in- terventions for preventing cardiovascular events. Cochrane Database Syst 632. Park JH, Saposnik G, Ovbiagele B, Markovic D, Towfighi A. 